Charles Schwab’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.3M | Sell |
545,486
-5,243
| -1% | -$143K | ﹤0.01% | 1820 |
|
|
2025
Q4 | $15M | Sell |
550,729
-3,144
| -0.6% | -$82.8K | ﹤0.01% | 1930 |
|
|
2025
Q3 | $14.3M | Buy |
553,873
+792
| +0.1% | +$18.4K | ﹤0.01% | 1929 |
|
|
2025
Q2 | $11.3M | Buy |
553,081
+17,237
| +3% | +$336K | ﹤0.01% | 1956 |
|
|
2025
Q1 | $9.73M | Sell |
535,844
-8,486
| -2% | -$190K | ﹤0.01% | 1967 |
|
|
2024
Q4 | $13.8M | Buy |
544,330
+5,474
| +1% | +$149K | ﹤0.01% | 1878 |
|
|
2024
Q3 | $18.3M | Buy |
538,856
+8,413
| +2% | +$321K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $19.6M | Buy |
530,443
+31,222
| +6% | +$1.18M | ﹤0.01% | 1693 |
|
|
2024
Q1 | $21M | Buy |
499,221
+89,830
| +22% | +$3.69M | ﹤0.01% | 1581 |
|
|
2023
Q4 | $16.2M | Buy |
409,391
+47,844
| +13% | +$1.41M | ﹤0.01% | 1715 |
|
|
2023
Q3 | $9.95M | Buy |
361,547
+10,818
| +3% | +$339K | ﹤0.01% | 1909 |
|
|
2023
Q2 | $11.9M | Buy |
350,729
+4,006
| +1% | +$135K | ﹤0.01% | 1829 |
|
|
2023
Q1 | $12.5M | Sell |
346,723
-1,530
| -0.4% | -$66K | ﹤0.01% | 1759 |
|
|
2022
Q4 | $15.5M | Buy |
348,253
+10,722
| +3% | +$383K | 0.01% | 1600 |
|
|
2022
Q3 | $9.49M | Buy |
337,531
+6,972
| +2% | +$214K | ﹤0.01% | 1871 |
|
|
2022
Q2 | $8.91M | Sell |
330,559
-6,249
| -2% | -$181K | ﹤0.01% | 1902 |
|
|
2022
Q1 | $11.5M | Buy |
336,808
+8,713
| +3% | +$279K | ﹤0.01% | 1878 |
|
|
2021
Q4 | $12.7M | Buy |
328,095
+5,639
| +2% | +$246K | ﹤0.01% | 1876 |
|
|
2021
Q3 | $17.4M | Buy |
322,456
+224,831
| +230% | +$10.6M | 0.01% | 1691 |
|
|
2021
Q2 | $3.27M | Buy |
97,625
+83,116
| +573% | +$2.28M | ﹤0.01% | 2555 |
|
|
2021
Q1 | $299K | Hold |
14,509
| – | – | ﹤0.01% | 3245 |
|
|
2020
Q4 | $255K | Sell |
14,509
-2,072
| -12% | -$37.3K | ﹤0.01% | 3222 |
|
|
2020
Q3 | $246K | Buy |
+16,581
| New | +$194K | ﹤0.01% | 3111 |
|
|
2018
Q2 | – | Sell |
-38,263
| Closed | -$1.34M | – | 3119 |
|
|
2018
Q1 | $1.34M | Sell |
38,263
-5,823
| -13% | -$226K | ﹤0.01% | 2438 |
|
|
2017
Q4 | $1.88M | Buy |
44,086
+6,012
| +16% | +$258K | ﹤0.01% | 2332 |
|
|
2017
Q3 | $1.63M | Sell |
38,074
-1,918
| -5% | -$71.9K | ﹤0.01% | 2356 |
|
|
2017
Q2 | $1.48M | Buy |
39,992
+5,990
| +18% | +$265K | ﹤0.01% | 2332 |
|
|
2017
Q1 | $1.84M | Buy |
34,002
+6,369
| +23% | +$332K | ﹤0.01% | 2229 |
|
|
2016
Q4 | $1.47M | Buy |
27,633
+1,350
| +5% | +$76.8K | ﹤0.01% | 2302 |
|
|
2016
Q3 | $1.59M | Buy |
26,283
+3,673
| +16% | +$229K | ﹤0.01% | 2242 |
|
|
2016
Q2 | $1.49M | Buy |
22,610
+1,294
| +6% | +$82.1K | ﹤0.01% | 2197 |
|
|
2016
Q1 | $1.21M | Sell |
21,316
-600
| -3% | -$67.5K | ﹤0.01% | 2266 |
|
|
2015
Q4 | $5.16M | Buy |
21,916
+1,187
| +6% | +$259K | 0.01% | 1503 |
|
|
2015
Q3 | $3.28M | Buy |
20,729
+405
| +2% | +$115K | ﹤0.01% | 1756 |
|
|
2015
Q2 | $7.69M | Buy |
20,324
+1,739
| +9% | +$691K | 0.01% | 1237 |
|
|
2015
Q1 | $7.77M | Buy |
18,585
+1,345
| +8% | +$481K | 0.01% | 1185 |
|
|
2014
Q4 | $4.72M | Buy |
17,240
+989
| +6% | +$246K | 0.01% | 1491 |
|
|
2014
Q3 | $3.16M | Buy |
16,251
+586
| +4% | +$128K | 0.01% | 1702 |
|
|
2014
Q2 | $3.83M | Sell |
15,665
-62
| -0.4% | -$14K | 0.01% | 1593 |
|
|
2014
Q1 | $4.17M | Buy |
15,727
+697
| +5% | +$267K | 0.01% | 1476 |
|
|
2013
Q4 | $5.46M | Buy |
15,030
+1,781
| +13% | +$686K | 0.01% | 1176 |
|
|
2013
Q3 | $7.52M | Buy |
13,249
+541
| +4% | +$186K | 0.02% | 821 |
|
|
2013
Q2 | $3.12M | Buy |
+12,708
| New | +$2.5M | 0.01% | 1431 |
|
Other funds holding CLDX
KCM
VCM
CC
EP